Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Pradaxa (dabigatran etexilate) - Important Safety Information from Boehringer Ingelheim as approved by the Irish Medicines Board 04.11.2011
Notice type:
3rd Party Publications
Date:
04/11/2011
Problem Or Issue:
Important Safety Information communication from Boehringer Ingelheim on the importance of assessing renal function in patients treated with Pradaxa (dabigatran etexilate).
Important Safety Information - Pradaxa
« Back
Date Printed: 07/05/2024